A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)

NCT02694328 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

561

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: ALKS 3831
DRUG: Olanzapine

Sponsor

Alkermes, Inc.